One of the biggest challenges the 340B community has faced over the years is a lack of program knowledge at a local level. As I reported in my May column, Community Voices for 340B (CV340B) is the first grassroots organization solely … [Read more...]
More States Embrace 340B Program as a Win-Win for Taxpayers, Patients and the General Public
November 23, 2019 by
Since I started my column earlier this year, I have written a number of pieces on the unprecedented attention that the 340B program is facing in state capitols. One of the more exciting developments is the growing interest among states to partner … [Read more...]
AIR340B Quietly Steps Up Advocacy Efforts
October 16, 2019 by
For those who have been involved in 340B advocacy for a while, you will likely have heard of AIR340B. The Alliance for Integrity and Reform of 340B (AIR340B) was launched by the pharmaceutical industry in 2013. Its members include the trade … [Read more...]
Hospital specialty pharmacies offer a solution to growing problems: medication access & affordability
August 8, 2019 by
Over the past year, I have learned a lot about specialty pharmacy and its importance to 340B providers and patients. A staggering 65% of the new drugs that came to market in 2018 were specialty drugs. These therapies can improve care and … [Read more...]
President’s Proposal to Require Drug Manufacturers to Disclose Prices in TV Ads
August 7, 2019 by
Ted Slafsky of Wexford Solutions Is Interviewed by Fox News Radio's daily podcast on the President's Proposal to Require Drug Manufacturers to Disclose Prices in TV Ads … [Read more...]
The View From the Nation’s Capital
July 1, 2019 by
This month’s column covers: 1) the significant uptick in drug manufacturer notices of overcharges to 340B providers and the importance of monitoring these developments. (2) The untold story of a little-known individual who played a … [Read more...]
A Welcome Addition to the 340B Debate
May 29, 2019 by
The pharmaceutical industry has successfully harnessed the power of patient groups to help in their advocacy efforts throughout state capitals and in Washington, D.C. According to the most recent data available, drug companies and their trade groups … [Read more...]
Why the President Should Hope He Loses ACA Court Battle
May 2, 2019 by
It has become axiomatic that Republican presidential candidates trounce their Democratic rivals in the South and other rural areas. The last time Democrats truly competed was in 1996, when Bill Clinton won such states as West Virginia, … [Read more...]
The View from Washington, D.C.
April 1, 2019 by
Clearing Off The Desk...... In my latest column, I am going to tackle a few issues that are timely and relevant to 340B stakeholders. Sometimes, I will take a deep dive into a particular subject, but there is so much going on right now with 340B, … [Read more...]
Be Vigilant on State 340B Activity
March 14, 2019 by
For the last two years, the 340B program has come under unprecedented scrutiny from the Trump Administration and Congress. In the prior congressional session, several studies were conducted by federal and congressional watchdogs, five hearings were … [Read more...]